Behind the Science: Behind the Impact of ART and PrEP on HIV Care and Prevention

Therapies within HIV care and prevention have come a long way in recent years. Not only is there the addition of new antiretroviral therapies (ART) being approved, but novel delivery of these medicines such as long-acting injectables are seeing greater utility and offering patients flexibility with newer treatment options. In addition, the advent of pre-exposure prophylaxis (PrEP) therapy is helping people who are at risk of HIV. Clinicians and stakeholders offer insights and perspective on these vital HIV care and prevention therapies and their true impact.